Preview Mode Links will not work in preview mode

CPG & CBD University Podcast

The CPG & CBD University Podcast, produced by Global Widget, LLC, is intended for audiences who are interested in learning more about CBD, health and wellness products. Each podcast episode will examine the burgeoning industry, including the latest news and trends, information around the sourcing, manufacturing, testing and distribution of CBD, health and wellness products, and any new product details from Global Widget’s in-house and private label brands.

Apr 30, 2021

Rod Kight, industry advocate and attorney, is back on the CBD University Podcast, as we look back at the biggest regulation-related stories of the first four months in 2021. Kight discusses the emergence of hemp compound, Delta-8 THC, along with other cannabinoids other than CBD, plus the effect that the PACT Act will...


Apr 22, 2021

Defense Boost is Global Widget’s first non-CBD brand, bringing health and wellness benefits through a line of immunity support gummies. VP of Sales Vince Gillen and Director of Strategic Business Partnerships Tracy Lane discuss the launch and our four varieties of Immunity Support Gummies available for retailers and...


Apr 16, 2021

A study by Brightfield Group, a leading consumer insights and market intelligence firm for the CBD and cannabis industries, shows that sleep in the new number one desirable product effect that consumers seek from CBD. According to the study, cannabis use “right before bed” nearly doubled in 2020 and for the first...


Apr 9, 2021

Compassion Kind works with governments, institutions, local leaders, organizations, foundations and businesses around the world to ensure the most vulnerable beings get assistance they need from their communities. As one recipient of our Million Dollar CBD Pet Product Giveaway, Compassion Kind has been using our pet...


Apr 2, 2021

Global Widget recently took part of a first-of-its-kind CBD industry clinical study examining the effect of CBD products on liver health. Validcare, which conducts patient-centered clinical trials, reported no preliminary evidence of liver disease in the more than 800 adults taking part in the study. Patrick McCarthy,...